Arcus Biosciences, Inc.
RCUSPharmaceutical Preparations · SIC 2834 · CIK 0001724521
Revenue FY2025
$33.0M
Net Income
$(353.0M)
EPS (Basic)
$-3.29
Net Margin
-1069.7%
ROE
-55.9%
Total Equity
$631.0M
Shares Out
127M
Arcus Biosciences, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2016–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 3 funds in our universe
Insider Transactions
Reading stored insider transactions…